Sinopharm (Beijing): BBIBP-CorV
Isi nke 1
1 Nnwale
ChiCTR2000032459
China
Isi nke 2
2 Ọnwụnwa
NCT04962906
Argentina
ChiCTR2000032459
China
Isi 3
Ọnwụnwa 6
NCT04984408
ChiCTR2000034780
United Arab Emirates
NCT04612972
Peru
NCT04510207
Bahrain, Egypt, Jordan, United Arab Emirates
NCT04560881, BIBP2020003AR
Argentina
NCT04917523
United Arab Emirates
Nkwado
Ndepụta Ngwa Mberede nke WHO Mba 59
Angola, Argentina, Bahrain, Bangladesh, Belarus, Belize, Bolivia (Plurinational State of), Brazil, Brunei Darussalam, Cambodia, Cameroon, Chad, China, Comoros, Egypt, Equatorial Guinea, Gabon, Gambia, Georgia, Guyana, Hungary, ndonesia 、 Iran (Islamic Republic of), Iraq, Jordan, Kyrgyzstan, Lao People's Democratic Republic.
Lebanon, Malaysia, Maldives, Mauritania, auritius, Mongolia, Montenegro, Morocco, Mozambique, Namibia, Nepal, Niger, North Macedonia, Pakistan, Paraguay, Peru, Philippines, Republic of Congo, enegal, Serbia, Seychelles, Sierra Leone Agwaetiti, Somalia, Sri Lanka, Thailand, Trinidad na Tobago, Tunisia, United Arab Emirates, Venezuela (Bolivarian Republic of), Viet Nam, Zimbabwe
COVID-19 Sinopharm BBIBP-CorV bụ ọgwụ mgbochi anaghị arụ ọrụ nke sitere na ụmụ irighiri nje na-eto eto nke na-enweghị ike ọrịa. Ọ bụ Sinopharm Holdings na ụlọ ọrụ Beijing nke Ngwa Ngwa Ngwa mepụtara nhọpụta ọgwụ mgbochi a.
Ọgwụ Sinopharm BBIBP-CorV na-arụ ọrụ site na ikwe ka usoro ahụ ji alụso ọrịa ọgụ mepụta ọgwụ mgbochi megide SARS-CoV-2 beta coronavirus. Ejirila ọgwụ mgbochi nje na -adịghị arụ ọrụ ruo ọtụtụ iri afọ, dịka ọgwụ mgbochi rabies na ọgwụ ịba ọcha n'anya A. E tinyela teknụzụ mmepe a nke ọma n'ọtụtụ ọgwụ mgbochi ama ama, dịka ọgwụ mgbochi rabies.
Sinopharm SARS-CoV-2 nje (ụdị WIV04 na nọmba ọbá akwụkwọ MN996528) dịpụrụ iche na onye ọrịa nọ n'ụlọ ọgwụ Jinyintan na Wuhan, China. A na-agbasa nje ahụ n'ọdịbendị n'usoro ahịrị Vero tozuru etozu, na-ejighị β-propiolactone (1: 4000 vol/vol, 2 ruo 8 Celsius C) rụọ ọrụ karịrị awa 48. Mgbe emechara nkọwa nke mpekere selụ na nyocha nke ọma, a na-eme β-propiolactone inactivation nke abụọ n'okpuru otu ọnọdụ dị ka enweghị ike izizi. Dị ka WHO si kwuo, etinyere ọgwụ mgbochi ahụ na 0,5 mg nke alum wee wụnye ya n'ime sirinji e dejujuru na 0,5 mL nke saline phosphate buffered saline na-enweghị ihe nchekwa.
Na Disemba 31, 2020, nchịkwa nchịkwa steeti kwupụtara nkwado nke ọgwụ mgbochi nnwale nke Sinopharm mepụtara.
Na Mee 7, 2021, Healthtù Ahụ Ike haswa kwupụtara nkwado nke ọgwụ mgbochi ahụ. Ndepụta ihe mberede nke WHO mere ka mba dị iche iche mee ngwa ngwa nkwado iwu nke ha ibubata na inye ọgwụ mgbochi COVID-19. Ttù Ndị Ọkachamara Ndụmọdụ WHO na Usoro Mgbochi Mgbochi ọrịa emechaala nyocha ya maka ọgwụ mgbochi ahụ. Dabere na ihe akaebe niile dịnụ, WHO na -atụ aro ọgwụ mgbochi abụọ, izu atọ na anọ dị iche, maka ndị okenye afọ 18 gbagowe. A na -eme nrụpụta ọgwụ mgbochi megide ọrịa Symptomatic na ụlọ ọgwụ na 79% maka afọ niile jikọtara.
Ndị otu American Medical Association bipụtara "Ọnwụnwa ụlọ ọgwụ Randomized: Mmetụta nke ọgwụ mgbochi SARS-CoV-2 na-adịghị arụ ọrụ na ọrịa COVID-19 Symptomatic na ndị okenye" na Mee 26, 2021, na-ekwubi na "na nyocha a nwapụtara nke ọma nke nnwale ụlọ ọgwụ enweghị usoro. Ndị okenye Ọgwụ mgbochi SARS-CoV-2 abụọ na-adịghị arụ ọrụ nke a na-enyocha nyocha nwa oge nke ọnwụnwa ụlọ ọgwụ agbadala belatara ihe ize ndụ nke COVID-19, na ajọ ihe ọjọọ adịghị ahụkebe. ” N'ime usoro nke atọ a na-anwale ndị okenye, ịdị irè nke ọgwụ mgbochi ọrịa nje abụọ na-adịghị arụ ọrụ na akara ngosi COVID-19 bụ 72.8% na 78.1%, n'otu n'otu. Ogwu 2 nwere ajọ ihe ọjọọ siri ike nke na-enwe otu oge na otu njikwa alum, naanị ọtụtụ enweghị njikọ na ịgba ọgwụ mgbochi ọrịa. Nnyocha nyocha chọpụtara na ọgwụ mgbochi abụọ ahụ butere ọgwụ mgbochi na -enweghị atụ, nke yiri nsonaazụ nke ikpe 1/2.
Otu WHO na-arụ ọrụ SAGE bipụtara nyocha nke ọgwụ mgbochi Sinopharm/BBIBP COVID-19 na Mee 10, 2021. Ọgwụ mgbochi COVID-19 nke GAVI gụnyere ihe nlele vial nke na-agwa ndị ọrụ ahụike ma echekwala ọgwụ mgbochi ahụ nke ọma ma ekpughebeghị ya. ikpo oke ọkụ. N'ihi nke a, mbibi, GAVI kọrọ na Mee 14, 2021. akara mmado mara mma nke Zebra Teknụzụ rụpụtara ma Temptime Corporation mere ya, nwere okirikiri nwere agba nwere agba dị n'etiti, nke ejiri kemịka na -enweghị agba nke na -amalite agba na -enweghị mgbagha. . Nke a na -agba ọchịchịrị iji nye ngosipụta nke mkpughe ikpo ọkụ. Ozugbo ekpughere vial ahụ ka okpomoku gafere oke nchekwa ya kacha mma, akụkụ ahụ na -agba ọchịchịrị karịa okirikiri, na -egosi na ekwesighi iji ọgwụ mgbochi ahụ ọzọ.
Nọmba ndebanye aha ọgwụ ọgwụ BBIBP-CorV COVID-19 nọmba ọgwụ ọgwụ: DB15807.
